Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 15;19(1):334.
doi: 10.1186/s12891-018-2253-x.

Up-regulated expression of E2F2 is necessary for p16INK4a-induced cartilage injury

Affiliations

Up-regulated expression of E2F2 is necessary for p16INK4a-induced cartilage injury

Xinnan Bao et al. BMC Musculoskelet Disord. .

Abstract

Background: Cartilage degradation would result in osteoarthritis (OA). p16INK4awas found in some age-related diseases. In this study, we aimed to determine the role of p16INK4a during OA and to investigate the underlying mechanisms.

Methods: Enzyme-linked immunosorbent assay (ELISA) was performed to test the activity of senescence-associated secretory phenotype (SASP). Real-time PCR (RT-PCR) and Western blot were used to determine the expressions of target genes.

Results: The increased expressions of p16INK4a and E2F2 were accompanied with cartilage degradation induced by IL-1β. Over-expression of p16INK4a enhanced the secretion of SASP markers (TGFβ, IL-6, IL-8, IL-1α, MMP3 and MMP13), reduced the expression of type II procollagen (COL2A1).Thus, the over-expression of p16INK4a lead to cartilage injury. Moreover, we found that the expression of E2F2 was enhanced in p16INK4a over-expression group, and that cartilage injury caused by p16INK4a was alleviated by depleting E2F2.

Conclusions: p16INK4a was up-regulated during the cartilage injury in OA. p16INK4a promoted cartilage injury by increasing the expression of E2F2. Thus, this study extends the molecular regulation network for understanding pathological progression of OA, and provides potential therapeutic target for OA.

Keywords: E2F2; Osteoarthritis (OA); Senescence-associated secretory phenotype (SASP); p16INK4a.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
(a) Western blot assay for the expression of Col2A1, p16INK4a and E2F2. (b) Real-time PCR (RT-PCR) for the expression of Col2A1, p16INK4a and E2F2. (c) Western blot assay for the expression of E2F2 in the cells treated with 10 ng/ml IL-1β.*P < 0.05,**P < 0.01 vs. control. Data are shown as mean ± SD, n = 4
Fig. 2
Fig. 2
(a) Determination of the secretion of SASP markers, including TGFβ, IL-6, IL-8, IL-1α, MMP3 and MMP13, using ELISA assay. **P < 0.01 vs. control. IL-1β, cells were treated with IL-1β. Data were shown as mean ± SD, n = 5
Fig. 3
Fig. 3
(a) ELISA assay for the secretion of SASP markers after the over-expression of p16INK4a. (b) RT-PCR for detecting the expressions of Col2A1, p16INK4a and E2F2. (c) The expressions of Col2A1, p16INK4a and E2F2 by Western blot assay. *P < 0.05 and **P < 0.01 vs. empty. Empty, cells were transfected with over-expression empty vector; p16INK4a, cells were transfected with p16INK4a over-expression vector. Data were shown as mean ± SD, n = 5
Fig. 4
Fig. 4
(a) The expression of Col2A1, p16INK4a and E2F2 determined by RT-PCR. (b-c) The expressions of Col2A1, p16INK4a and E2F2 determined by Western blot assay. Empty group, cells were transfected with over-expression empty vector and siRNA negative control; p16INK4a group, cells were transfected with p16INK4a over-expression vector and siRNA negative control; E2F2 group, cells were transfected with E2F2 over-expression vector and siRNA negative control; p16INK4a + E2F2 group, cells were over-expressed with E2F2 and p16INK4a and siRNA negative control; si-E2F2 group, cells were transfected with si-E2F2 and over-expression empty vector; p16INK4a + si-E2F2 group, cells were transfected with si-E2F2 and p16INK4a. *P < 0.05 vs. empty, #P < 0.05 vs. p16INK4a. Data were shown as mean ± SD, n = 4
Fig. 5
Fig. 5
ELISA assay for SASP markers. Empty group, cells were transfected with over-expression empty vector and siRNA negative control. p16INK4a group, E2F2 indicated the over-expressions of p16INK4a and E2F2 respectively. Si-E2F2 indicated the depletion of E2F2. *P < 0.05 vs. empty. #P < 0.05, vs. p16INK4a. Data were shown as mean ± SD, n = 5
Fig. 6
Fig. 6
(a) Cell proliferation was detected by WST-1 cell counting kit. *P < 0.05 vs. control. Data were shown as mean ± SD, n = 5. (b) The expressions of CDC6, MCM6, p16INK4a and E2F2 determined by RT-PCR. Data were shown as mean ± SD, n = 4.*P < 0.05 vs. empty.&P < 0.05, vs. p16INK4a

References

    1. Yang Ji Hye, Lee Kiheon, Jung Se Young, Bae Woo Kyung, Ju Hye Jin, Cho In Young, Song Jae Kyeong, Park Hwa Yeon, Han Jong-Soo, Lee Ga-Hye, Bae Ye Seul. Osteoarthritis Affects Health-Related Quality of Life in Korean Adults with Chronic Diseases: The Korea National Health and Nutritional Examination Surveys 2009–2013. Korean Journal of Family Medicine. 2017;38(6):358. doi: 10.4082/kjfm.2017.38.6.358. - DOI - PMC - PubMed
    1. Dillon CF, Rasch EK, Gu Q, Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the third National Health and nutrition examination survey 1991-94. J Rheumatol. 2006;33(11):2271–2279. - PubMed
    1. Katz SI. Commentary: setting priorities for research funding at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) J Am Acad Dermatol. 2015;73(3):392–394. doi: 10.1016/j.jaad.2015.06.014. - DOI - PubMed
    1. Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ. Osteoarthritis. Lancet. 2015;386(9991):376–387. doi: 10.1016/S0140-6736(14)60802-3. - DOI - PubMed
    1. Loeser RF. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthr Cartil. 2009;17(8):971–979. doi: 10.1016/j.joca.2009.03.002. - DOI - PMC - PubMed

MeSH terms